Newly diagnosed? Start here.
What is cutaneous lymphoma?
Cutaneous lymphoma is a general term for many lymphomas of the skin including:
- cutaneous T-cell lymphoma
- mycosis fungoides
- Sézary syndrome
- cutaneous anaplastic large cell lymphoma
- adult T-cell leukemia/lymphoma
- peripheral T-cell lymphoma
- lymphomatoid granulomatosis
- granulomatous slack skin disease
- B-cell lymphoma
- pagetoid reticulosis
- and more read more...
Join our e-mailing list!
Want to get the latest updates on advocacy and research? We send out periodic updates via email, and do not share your email address. Join here
FREE Educational Materials Available
The Cutaneous Lymphoma Foundation has several educational materials available. read more...
In the News
March 4, 2008: Potential Marker for Cutaneous T-Cell Lymphoma ID'd
December 5, 2007:Gloucester Pharmaceuticals Announces Presentation of Romidepsin
December 5, 2007: Novartis Plans for New Cancer Drugs
November 26, 2007: CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
November 26, 2007: Marketing Application for Vorinostat Filed in Europe for the Treatment of Advanced, Refractory Cutaneous T-Cell Lymphoma
October 13, 2007: BioCryst Initiates Enrollment In Pivotal Trial Of Forodesine HCL In Patients With Cutaneous T-Cell Lymphoma (CTCL)
October 11, 2007: Genmab Amends HUMAX-CD4 Pivotal Study in CTCL: Receives Orphan Drug Designation for Nodal T-cell Lymphoma
July, 2007: The National Comprehensive Cancer Network Practice guidelines in Oncology for Mycosis Fungoides/Sezary Syndrome have just come out. Here is the link to download the document (MF/SS guidelines are on pages 58-63)
July 17, 2007: Cutaneous T-Cell Lymphoma Grows More Common
June 29, 2007: Genmad Announces Final HUMAX-CD4 Phase II CTCL Data
June 12, 2007: CuraGen Presents Update on Clinical Development Program for Belinostat
June 5, 2007: ONTAK(R) (denileukin Diftitox) Achieves 49.1% Overall Response Rate In Phase III Trial Of Cutaneous T-Cell Lymphoma (CTCL)
June 5, 2007: Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
May 31, 2007: Allos Therapeutics Initiates Phase I/II Study of PDX and Gemcitabine in Patients with Non-Hodgkin’s Lymphoma or Hodgkin’s Disease
May 1, 2007: Clinical Trial of Romidepsin
April 30, 2007: Cyclacel Pharmaceuticals begins Phase II study of oral sapacitabine in patients with advanced cutaneous T-cell lymphoma
February 6, 2007: Cyclacel Reports Phase I Sapacitabine Data in Patients with Advanced (2º) Leukemias and Myelodysplastic Syndromes at 2007 ASCO Annual Meeting
|
Cutaneous Lymphoma Foundation Welcomes New Executive Director
 The Cutaneous Lymphoma Foundation welcomed its new executive director, Gary H. Ross, on January 1, 2008. Judy Jones, Cofounder and previous Executive Director, has moved into the position of Board President, and will continue to be active with the organization that she helped to form ten years ago. read more... |
Cutaneous Lymphoma Foundation Bike Jerseys
 Show your support with these custom bike jerseys!
|
Cutaneous Lymphoma Patient
Educational Forums |
 Seattle, Washington: May 10, 2008
Lymphoma Workshop, in collaboration with the Lymphoma Research Foundation
Registration open! |
 Detroit, Michigan: May 31, 2008
Cutaneous Lymphoma Patient Educational Forum
Registration open! |
 San Francisco, California: September 26 to 28, 2008
North American Educational Forum on Lymphoma, presented in collaboration with the Lymphoma Research Foundation
Details coming soon! |
 Minneapolis, Minnesota: October 18, 2008
Lymphoma Workshop , presented in collaboration with the Lymphoma Research Foundation
Details coming soon! |
 Pittsburgh, Pennsylvania: October 25, 2008
11th Annual Brian V. Jegasothy Support Group for CTCL, presented in partnership with the University of Pittsburgh Medical Center
Details coming soon! |
 Brooklyn, New York: November 8, 2008
Lymphoma Workshop , presented in collaboration with the Lymphoma Research Foundation
Details coming soon! |
| Did you miss a Cutaneous Lymphoma Patient Educational Forum? Many of the presentations from past events are available here. |
The most reliable, up-to-date information about cancer is available in Spanish! The National Cancer Institute (NCI) is pleased to announce the launch of a new Spanish Web site, Cancer.gov en español. Information about mycosis fungoides and Sezary syndrome is available en español here. (This link will open in a new window.)
Medicare Formulary Finder for Prescription Drug Plans
The Formulary Finder for Prescription Drug Plans will allow you to find plans in your state that match your required drug list. Click here to visit the Formulary Finder for Prescription Drug Plans on medicare.gov.
What happened to the Mycosis Fungoides Foundation? Read the press release... |
